Derm-Biome Pharmaceuticals to develop skincare treatment that promotes skin health and longevity

VANCOUVER, British Columbia, Aug. 13, 2024 (GLOBE NEWSWIRE) -- Derm-Biome Pharmaceuticals Inc, a Vancouver-based biopharmaceutical company focused on skin health and healthy aging, is excited to announce the development of a novel, science-backed skincare treatment aimed at targeting some of the root causes of skin aging, such as chronic inflammation and cellular damage. Derm-Biome’s compounds exhibit a broad range of beneficial effects, including anti-inflammatory, antioxidant, and antimicrobial activities. In preclinical studies, topical application of Derm-Biome’s compounds has produced rapid and noticeable improvements to the appearance of skin.  Read More